PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsepidermolysis bullosa
MeSH D004820 - epidermolysis bullosa
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012873:Genetic skin diseases
4 Companies
4 Drugs
$
Success rate
D012868:Skin abnormalities
0 Companies
0 Drugs
Success rate
D012872:Vesiculobullous skin diseases
0 Companies
0 Drugs
Success rate
D004820: 
Epidermolysis bullosa
1 Company
1 Drug
$
Success rate
D016108:Epidermolysis bullosa dystrophica
1 Company
0 Drugs
Success rate
D016109:Junctional epidermolysis bullosa
1 Company
0 Drugs
Success rate
D016110:Epidermolysis bullosa simplex
0 Companies
0 Drugs
Success rate
D016107:Epidermolysis bullosa acquisita
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Chiesi FarmaceuticiBirch triterpenes Filsuvez 2025-06-21 2023-12-18   
Clinical Trials
Historical Success Rate
Phase 1
73%
11/15
Phase 2
8%
1/13
Phase 3
0%
0/6
Approved: 0Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Chiesi Farmaceutici
Birch triterpenes
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use